Agency Releases First 10 Negotiated Drug Prices for Initial Price Applicability Year 2026; Projects $6 Billion in Medicare Program Savings and $1.5 Billion in Out-of-Pocket Savings

Agency Releases First 10 Negotiated Drug Prices for Initial Price Applicability Year 2026; Projects $6 Billion in Medicare Program Savings and $1.5 Billion in Out-of-Pocket Savings

the Centers for Medicare and Medicaid Services (CMS) released the negotiated Maximum Fair Prices (MFPs) for 10 drugs covered under Medicare Part D, which will take effect on January 1, 2026 (press release, fact sheet, one-pager). These are the first 10 drugs that will see significant price reductions under the Inflation Reduction Act’s drug price negotiation program, with prices dropping… (Colocho, August 15, 2024) #Drug Pricing, #Medicare Part D